Edges in Network
Network | GSE5851_top8000 - GSE5851 - SiGN-BN NNSR |
Network Description | Phase II exploratory pharmacogenomics study of cetuximab monotherapy in patients with advanced metastatic CRC |
Node | IGLV2-18///IGLV3-19///IGL@ |
Upstream (Parents) |
---|
(<<) LOC100134331///LOC100126583///LOC652128///LOC642131///VSIG6///IGHV4-31///IGHM///IGHG4///IGHG3///IGHG1///IGHD///IGHA2///IGHA1///IGH@ → IGLV2-18///IGLV3-19///IGL@ |
(<<) LOC100126583///IGHV4-31///IGHV@///IGHM///IGHG3///IGHG2///IGHG1///IGHD///IGHA2///IGHA1///IGH@ → IGLV2-18///IGLV3-19///IGL@ |
(<<) IGLV2-11///IGLV2-18///IGLV2-23///IGLC1///IGL@ → IGLV2-18///IGLV3-19///IGL@ |
(<<) FAM20B → IGLV2-18///IGLV3-19///IGL@ |
(<<) IGHV4-31///IGHV@///IGHM///IGHG3///IGHG1///IGHA1 → IGLV2-18///IGLV3-19///IGL@ |
(<<) IGKV1OR2-118 → IGLV2-18///IGLV3-19///IGL@ |
Downstream (Children) |
---|
IGLV2-18///IGLV3-19///IGL@ → VPS16 (>>) |
IGLV2-18///IGLV3-19///IGL@ → CCR9 (>>) |
IGLV2-18///IGLV3-19///IGL@ → MED24 (>>) |
IGLV2-18///IGLV3-19///IGL@ → PLSCR2 (>>) |
IGLV2-18///IGLV3-19///IGL@ → CUL3 (>>) |